Mira Katan
Serum neurofilament light chain in patients with acute cerebrovascular events.
De Marchis G, Katan M, Barro C, Fladt J, Traenka C, Seiffge D, Hert L, Gensicke H, Disanto G, Sutter R, Peters N, Sarikaya H, Simonetti B, El-Koussy M, Engelter S, Lyrer P, Christ-Crain M, Arnold M, Kuhle J, Bonati L. Serum neurofilament light chain in patients with acute cerebrovascular events. Eur J Neurol 2018; 25:562-568.
24.01.2018Serum neurofilament light chain in patients with acute cerebrovascular events.
24.01.2018Eur J Neurol 2018; 25:562-568
De Marchis Gian Marco, Katan Mira, Barro Christian, Fladt Joachim, Traenka Christopher, Seiffge David Julian, Hert Lisa, Gensicke Henrik, Disanto Giulio, Sutter Raoul, Peters Nienske, Sarikaya Hakan, Simonetti Barbara Goeggel, El-Koussy Marwan, Engelter Stefan T, Lyrer Philippe A, Christ-Crain Mirjam, Arnold Marcel, Kuhle Jens, Bonati Leo H
Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke.
De Marchis G, Schneider J, Weck A, Fluri F, Fladt J, Foerch C, Müller-Stich B, Luft A, Christ-Crain M, Arnold M, Katan M. Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke. Neurology 2018; 90:e455-e465.
10.01.2018Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke.
10.01.2018Neurology 2018; 90:e455-e465
De Marchis Gian Marco, Schneider Juliane, Weck Anja, Fluri Felix, Fladt Joachim, Foerch Christian, Müller-Stich Beat P, Luft Andreas R, Christ-Crain Mirjam, Arnold Marcel, Katan Mira
Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies.
Kelly P, Albers G, Chatzikonstantinou A, De Marchis G, Ferrari J, George P, Katan M, Knoflach M, Kim J, Li L, Lee E, Olivot J, Purroy F, Raposo N, Rothwell P, Sharma V, Song B, Tsivgoulis G, Walsh C, Xu Y, Merwick A. Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies. Lancet Neurol 2016; 15:1238-1247.
11.10.2016Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies.
11.10.2016Lancet Neurol 2016; 15:1238-1247
Kelly Peter, Albers Gregory W, Chatzikonstantinou Anastasios, De Marchis Gian Marco, Ferrari Julia, George Paul, Katan Mira, Knoflach Michael, Kim Joo Sung, Li Linxin, Lee Eun-Jae, Olivot Jean-Marc, Purroy Francisco, Raposo Nicolas, Rothwell Peter M, Sharma Vijay K, Song Bo, Tsivgoulis Georgios, Walsh Cathal, Xu Yuming, Merwick Aine
Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.
De Marchis G, Weck A, Audebert H, Benik S, Foerch C, Buhl D, Schuetz P, Jung S, Seiler M, Morgenthaler N, Mattle H, Müller-Stich B, Christ-Crain M, Arnold M, Katan M. Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study. Stroke 2014; 45:2918-23.
28.08.2014Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.
28.08.2014Stroke 2014; 45:2918-23
De Marchis Gian Marco, Weck Anja, Audebert Heinrich J, Benik Steffen, Foerch Christian, Buhl Daniela, Schuetz Philipp, Jung Simon, Seiler Marleen, Morgenthaler Nils G, Mattle Heinrich Paul, Müller-Stich Beat P, Christ-Crain Mirjam, Arnold Marcel, Katan Mira
Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.
De Marchis G, Katan M, Weck A, Fluri F, Foerch C, Findling O, Schuetz P, Buhl D, El-Koussy M, Gensicke H, Seiler M, Morgenthaler N, Mattle H, Müller-Stich B, Christ-Crain M, Arnold M. Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study. Neurology 2013; 80:1278-86.
06.03.2013Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.
06.03.2013Neurology 2013; 80:1278-86
De Marchis Gian Marco, Katan Mira, Weck Anja, Fluri Felix, Foerch Christian, Findling Oliver, Schuetz Philipp, Buhl Daniela, El-Koussy Marwan, Gensicke Henrik, Seiler Marlen, Morgenthaler Nils G, Mattle Heinrich Paul, Müller-Stich Beat P, Christ-Crain Mirjam, Arnold Marcel
Copeptin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage.
Fung C, De Marchis G, Katan M, Seiler M, Arnold M, Gralla J, Raabe A, Beck J. Copeptin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage. PloS one 2013; 8:e53191.
11.01.2013Copeptin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage.
11.01.2013PloS one 2013; 8:e53191
Fung Christian, De Marchis Gian Marco, Katan Mira, Seiler Marleen, Arnold Marcel, Gralla Jan, Raabe Andreas, Beck Jürgen
Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk study.
De Marchis G, Katan M, Weck A, Brekenfeld C, Mattle H, Buhl D, Müller-Stich B, Christ-Crain M, Arnold M. Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk study. Int J Stroke 2012; 8:214-8.
15.02.2012Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk study.
15.02.2012Int J Stroke 2012; 8:214-8
De Marchis Gian Marco, Katan Mira, Weck Anja, Brekenfeld Caspar, Mattle Heinrich Paul, Buhl Daniela, Müller-Stich Beat P, Christ-Crain Mirjam, Arnold Marcel